KATRINA GARRIGAN: Open Payments
NPI 1669990065 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,606 in 180 payments from 14 companies in 2025. Trend: 2023 $1,416 · 2024 $1,744 · 2025 $2,606
Food & beverage: $2,606
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 38 | $476 |
| ABBVIE INC. | 26 | $409 |
| E.R. Squibb & Sons, L.L.C. | 23 | $320 |
| Vanda Pharmaceuticals Inc. | 9 | $261 |
| Neurocrine BioSciences, Inc. | 31 | $240 |
| Janssen Pharmaceuticals, Inc | 5 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $208 |
| Otsuka America Pharmaceutical, Inc. | 14 | $207 |
| Alkermes, Inc. | 12 | $170 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: VRAYLAR, COBENFY, UZEDY, INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, SPRAVATO.
Industry payments across NY — which companies pay providers there.
